Evox Technology


Although exosomes are a novel form of biotherapeutics their production and purification is highly similar to conventional monoclonal antibody production, both in terms of upstream and downstream processes. Evox is therefore investing significant resources to capitalize on advances made within protein production and our exosome manufacturing lines rely on some of the latest technologies for cell line development, cell culturing, exosome harvesting, and exosome purification. We also focus intensely on optimizing the pharmaceutical compositions, to ensure that we harness the biology and the potency of exosomes as efficiently as possible.